Point72 Asset Management
CRBP icon

Point72 Asset Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Point72 Asset Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$482K Sell
51,296
-23,838
-32% -$201K ﹤0.01% 3132
2025
Q4 		$612K Buy
+75,134
New +$927K ﹤0.01% 3140
2024
Q3 		– Sell
-216,515
Closed -$9.8M – 2040
2024
Q2 		$9.8M Sell
216,515
-485,082
-69% -$20.4M 0.03% 625
2024
Q1 		$27.5M Buy
+701,597
New +$17.3M 0.07% 351
2020
Q3 		– Sell
-50,000
Closed -$12.6M – 949
2020
Q2 		$12.6M Buy
+50,000
New +$10.1M 0.08% 284
2017
Q3 		– Sell
-6,302
Closed -$1.19M – 902
2017
Q2 		$1.19M Buy
+6,302
New +$1.24M 0.01% 713

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Asset Management's CRBP Position: Q1 2026 in Review

Point72 Asset Management reduced its Corbus Pharmaceuticals (CRBP) stake by 32% in Q1 2026, selling an estimated $201K and leaving 51,296 shares worth $482K. The position accounts for ﹤0.01% of the portfolio, ranked #3132.

Point72 Asset Management first reported a position in CRBP in Q2 2017 and has held it in 6 quarters since. The position peaked at $27.5M in Q1 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Point72 Asset Management held 51,296 shares of Corbus Pharmaceuticals worth $482K as of Q1 2026.
  • Point72 Asset Management sold 23,838 Corbus Pharmaceuticals shares in Q1 2026, an estimated $201K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3132 holding.
  • Point72 Asset Management first reported a position in Corbus Pharmaceuticals in Q2 2017 and has held it in 6 quarters since.
  • Point72 Asset Management's Corbus Pharmaceuticals position peaked at $27.5M in Q1 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.